Ignite Creation Date:
2024-05-05 @ 4:36 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00271765
Status:
COMPLETED
Last Update Posted:
2006-11-29
First Post:
2006-01-03
Brief Title:
A Study of INO-1001 an Intravenous PARP Poly ADP Ribose Polymerase Inhibitor in Acute Heart Attack Patients Undergoing Primary Percutaneous Coronary Intervention
Sponsor:
Inotek Pharmaceuticals Corporation
Organization:
Inotek Pharmaceuticals Corporation
Organization Data
Organization:
Inotek Pharmaceuticals Corporation
Class:
INDUSTRY
Study ID:
IPC-15-2003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Inotek Pharmaceuticals Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None